Navigation Links
Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery
Date:12/17/2008

fficient capital when needed, or at all, particularly in light of the recent, unprecedented volatility in the overall capital markets; and other risks detailed in Cadence's prior press releases as well as in the company's periodic public filings with the Securities and Exchange Commission.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Cadence(TM), Acetavance(TM) and Omigard(TM) are trademarks of Cadence Pharmaceuticals, Inc.

     Contacts:
     William R. LaRue                     Anna Gralinska
     SVP & Chief Financial Officer        Director, Investor Relations
     Cadence Pharmaceuticals, Inc.        Cadence Pharmaceuticals, Inc.
     858-436-1400                         858-436-1452

'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
2. Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance(TM)
3. Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results and Provides Corporate and Clinical Program Overview
4. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter Financial Results and Provide a Clinical Program Update on May 6, 2008
5. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 30, 2015 , ... In an effort to provide the twenty four hour ... change in his practice. , The decision will also allow him to spend more ... be transferring his in-patient admissions to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... for people on the go. With no water needed, the refreshing berry-flavored tablets ... simple way to get the natural ingredients that may help with body detoxification, ...
(Date:7/30/2015)... MD (PRWEB) , ... July 30, 2015 , ... ... serving the Mid-Atlantic region, is the recipient of three awards in the Service ... for communications programs created for Choptank Transport, KRM Development Corporation and University of ...
(Date:7/30/2015)... Diego, CA (PRWEB) , ... July 30, 2015 ... ... has been consistently growing into one of the largest, family-owned low cost service ... across residential and commercial applications, as well as growing their company to meet ...
(Date:7/30/2015)... County, CA (PRWEB) , ... July 30, 2015 , ... ... County, Los Angeles, Riverside, and San Bernardino, recently announced that the Centers for Medicare ... new rating system of home health care providers. 24/7 Care At Home’s agency is ...
Breaking Medicine News(10 mins):Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 2Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 3Health News:Zaca Life Introduces Recovery Chewable Packets with Setria® Glutathione and Sustamine® L-Alanyl-L-Glutamine 4Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2
... , , , ... (Hologic or the Company) (Nasdaq: HOLX ), a ... systems and surgical products dedicated to serving the healthcare needs ... (FDA) cleared the Company,s 510K application for the MammoSite((R)) ML ...
... , NEW YORK, Sept. 5 Reporter Jim ... 5, 2009) Mr. Rutenberg accused me of making false statements, but ... statements are true. Mr. Rutenberg is the one writing falsehoods. ... are not what,s needed. The focus should be on the health ...
... ... of Hissey Kientz, LLP is warning consumers to immediately stop ... prior to a colonoscopy. In December 2008 the Food and Drug Administration ... the FDA’s warnings about the dangers of Phospho-soda and Fleet’s recall of ...
... ... winners of the 2009 research grants. This year,s grantees will explore such important ... opioids enhance migraine pain. , ... (PRWEB) September 5, 2009 -- The Migraine Research Foundation (MRF), the only ...
... WASHINGTON, Sept. 4 The California Nurses ... of Medicine for recommending strong patient safety protections for ... ongoing H1N1/swine flu pandemic--and calls on the Centers for ... , "America,s registered nurses have significant ...
... dual parents for child,s success , SATURDAY, Sept. 5 (HealthDay ... one- or two-parent household -- may help a child succeed ... findings, by an Ohio State University professor, challenge the conventional ... single parent marrying or moving in with a partner may ...
Cached Medicine News:Health News:FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer 2Health News:FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer 3Health News:FDA Clears Hologic's MammoSite(R) ML Radiation Therapy System for the Treatment of Early-Stage Breast Cancer 4Health News:Betsy McCaughey Addresses New York Times: Charges of Falsehoods But No Evidence 2Health News:Betsy McCaughey Addresses New York Times: Charges of Falsehoods But No Evidence 3Health News:Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products 2Health News:Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products 3Health News:Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products 4Health News:Migraine Research Foundation Announces Winners of 2009 Research Grants 2Health News:Migraine Research Foundation Announces Winners of 2009 Research Grants 3Health News:Migraine Research Foundation Announces Winners of 2009 Research Grants 4Health News:America's Registered Nurses Applaud New Institute of Medicine H1N1/Swine Flu Safety Recommendations -- and Call on CDC to Maintain Stringent Safety Guidelines 2Health News:Single Parents May Do as Well as Two: Study 2
(Date:7/30/2015)... July 30, 2015 IRIDEX Corporation (NASDAQ: ... second quarter 2015 financial results after the market closes ... with the release, the Company will host a conference ... Eastern Time on Thursday, August 6, 2015 ... other business developments. Interested parties may access ...
(Date:7/30/2015)... 30, 2015  Unichem Pharmaceuticals ( USA ... Hydrochlorothiazide tablets 25 mg 1000-count bottle to the consumer ... measure due to the identification of a Clopidogrel tablet ... The risk associated with mistakenly taking a Clopidogrel ... probability of experiencing Clopidogrel,s side effects which include bleeding ...
(Date:7/30/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... regarding the notice it received on May 21, 2015 ... the Company was below certain of the Exchange,s continued ... 1101 of the NYSE MKT Company Guide, due to ...
Breaking Medicine Technology:IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Unichem Pharmaceuticals (USA), Inc. Issues a Voluntary Nationwide Recall of Hydrochlorothiazide Tablets Due to the Potential Presence of Foreign Tablets 2TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
...   Unigene Laboratories, Inc. (OTCBB: UGNE), today announced ... position of Chief Financial Officer. In this newly created position, ... company,s executive leadership team and lead the strategic direction ... Mr. Moskowitz joins Unigene after spending the previous ...
... 2012 Reportlinker.com announces that a new ... catalogue: Vaccines - ... This market research report package offers ... situation, trends and future outlook for vaccines ...
Cached Medicine Technology:Unigene Appoints David Moskowitz as Chief Financial Officer 2Unigene Appoints David Moskowitz as Chief Financial Officer 3Unigene Appoints David Moskowitz as Chief Financial Officer 4Unigene Appoints David Moskowitz as Chief Financial Officer 5Vaccines - Asia 2
... The Integra II SP MRI-Compatible Anesthesia System is ... using more than one type of anesthetic agent. ... vaporizers and due to its wider stance, has ... and ventilator bellows assembly is utilized in both ...
The very bright medical maginifier lamp for examination and labratory....
... is the Market leader in soft tissue ... DePuy Mitek has developed the latest evolution ... shoulder repair. ORTHOCORD Suture is as strong ... market. Most importantly, ORTHOCORD Suture handles like ...
... The SuturTek 360Fascia Closure Deviceprotects ... suture needlesticks and the threat of ... suturing, while at the same time ... safely, quickly, and easily. The SuturTek ...
Medicine Products: